2 Result: Alvotech
Alvotech, Teva, JNJ Settle on AVT04; Teck Resources Evaluating Glencore Proposal
June 12th, 2023
Alvotech (Nasdaq: ALVO) and an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) have announced a settlement and license agreement with Johnson & Johnson (NYSE: JNJ) concerning AVT04, Alvotech's proposed biosimilar to Stelara (ustekinumab. Read more
The Week On The Horizon: Brady Corporation, Canadian Solar, Canada Goose, Alvotech
May 14th, 2023
On Thursday, May 18, investors and analysts will be keeping a close eye on several notable companies set to report their financial results. Brady Corporation (NYSE: BRC) is expected to release its fiscal 2023 third quarter financial results . Read more
Load More Content
Want To Find Some News?
News By Industries
Recent Post
-
Countdown to Earnings: Nutanix, CrowdStrike, and Synopsys on Deck
August 23rd, 2026Investors Eye Semtech, Intuit, and nCino as Earnings Loom
August 22nd, 2026FTC Files Amicus Brief to Protect Competition in Biologic Drug Markets
August 21st, 2026
Member Login